Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,611 | -52,489 | -50,187 | -44,978 | -36,472 |
| Depreciation Amortization | 2,668 | 4,117 | 5,529 | 6,247 | 5,070 |
| Accounts receivable | -1,070 | -118 | 2,210 | 303 | -31 |
| Accounts payable and accrued liabilities | 1,812 | 997 | -1,976 | -2,585 | 1,231 |
| Other Working Capital | 9,374 | -7,327 | -1,750 | 22,938 | 32,421 |
| Other Operating Activity | -208 | 4,708 | 1,108 | -12,833 | -24,299 |
| Operating Cash Flow | $-59,035 | $-50,112 | $-45,066 | $-30,908 | $-22,080 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,395 | -12,957 | 2,253 | N/A | N/A |
| PPE Investments | -2,570 | -619 | 425 | -2,001 | -12,582 |
| Net Acquisitions | N/A | N/A | 25,715 | N/A | N/A |
| Investing Cash Flow | $-1,175 | $-13,576 | $28,393 | $-2,001 | $-12,582 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,500 | 2,600 | 1,000 | 10,000 | 24,000 |
| Debt Repayment | -4,875 | -7,341 | -2,776 | -2,491 | -2,367 |
| Common Stock Issued | 84,347 | 71,789 | 28,010 | 14,796 | 22,159 |
| Other Financing Activity | 191 | 310 | 1,355 | 500 | 500 |
| Financing Cash Flow | $81,163 | $67,358 | $27,589 | $22,805 | $44,292 |
| Beginning Cash Position | 16,811 | 13,141 | 2,225 | 12,329 | 2,699 |
| End Cash Position | 37,764 | 16,811 | 13,141 | 2,225 | 12,329 |
| Net Cash Flow | $20,953 | $3,670 | $10,916 | $-10,104 | $9,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,035 | -50,112 | -45,066 | -30,908 | -22,080 |
| Capital Expenditure | -2,570 | -664 | -320 | -2,063 | -12,582 |
| Free Cash Flow | -61,605 | -50,776 | -45,386 | -32,971 | -34,662 |